Benefit for Companies
GeneRight™ will enable pharmaceutical companies and other buyers of data to search for and license medical data tailored to their needs for research and development. GeneRight™ can help companies evolve to growing data needs.
・fast & flexible cohort selection
・fully legal & compliant
GeneRight™ is building a bioinformatic database derived from properly consented liver cancer, lung cancer and rare disease biosamples. This data will be available for sale in October 2019—we are now pre-marketing the data.
・9,000+ matched liver cancer biosamples
・3,000+ matched lung cancer biosamples
・350 rare disease biosamples
・deriving from Han Chinese genome
・quality controlled sample handling
・paired clinical data attributes
Current health care data demands exceed US$25 billion and is growing at about 27% per year. *